Safety and Efficacy of Eluxadoline in Patients with Irritable Bowel Syndrome-Diarrhea With or Without Bile Acid Diarrhea: Open-Label Study.

Priya VijayvargiyaMargaret Breen-LylesSara Linker NordDaniel MaselliIrene BusciglioRamesh BoinpallyAnna MuslinTimothy J CarrothersMichael Camilleri

Published in: Digestive diseases and sciences (2022)

Eluxadoline is similarly efficacious in the treatment of IBS-D and BAD, and it appears to be safe and efficacious as documented in large clinical trials.

Keyphrases

irritable bowel syndrome
clinical trial
open label
phase ii
phase iii
squamous cell carcinoma
randomized controlled trial
combination therapy
double blind
smoking cessation